{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:23:33Z","timestamp":1787660613206,"version":"build-2736575974"},"reference-count":143,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Colorectal cancer (CRC) progression and metastasis, as well as tolerance to therapy, are driven not only by genetic alterations but also by cell-state plasticity. Oncofetal reprogramming (OnF) refers to the reactivation of fetal intestinal developmental or injury-repair programs in tumor cells, thereby weakening adult lineage identity and enhancing the capacity for state transitions. Available evidence suggests that, in specific Wnt-dependent or APC-aberrant contexts, YAP\/TAZ\u2013TEAD and AP-1 may act cooperatively to establish and maintain the OnF state, whereas Wnt, EGFR\u2013MAPK, FGF\/FGFR, TGF-\u03b2, and extracellular matrix signaling contribute to its establishment and maintenance in a context-dependent manner. The OnF state can also intersect with epithelial\u2013mesenchymal plasticity, dynamic stemness, drug-tolerant persister states, and immune and stromal niches, collectively increasing cellular heterogeneity, adaptability to therapy, and relapse potential in CRC. This review discusses the conceptual boundaries and operational criteria for identifying OnF in CRC, examines its regulatory mechanisms, plasticity-associated phenotypes, and translational relevance, and emphasizes the importance of distinguishing direct evidence of OnF from evidence of related plasticity mechanisms. Further elucidation of the OnF state may facilitate biomarker development and anti-plasticity therapies, although its clinical translation will require standardized state classification and clinical validation.<\/jats:p>","DOI":"10.3389\/fonc.2026.1912866","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:38:55Z","timestamp":1787657935000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncofetal reprogramming and cellular plasticity in colorectal cancer: from mechanisms to clinical translation"],"prefix":"10.3389","volume":"16","author":[{"given":"Haoyu","family":"Wang","sequence":"first","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songhao","family":"Liu","sequence":"additional","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Deng","sequence":"additional","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Han","sequence":"additional","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-024-00934-z","article-title":"Mechanisms of metastatic colorectal cancer","volume":"21","author":"Ca\u00f1ellas-Socias","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00595-y","article-title":"Cancer cell plasticity during tumor progression, metastasis and response to therapy","volume":"4","author":"P\u00e9rez-Gonz\u00e1lez","year":"2023","journal-title":"Nat Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-23-1067","article-title":"Lineage plasticity: The new cancer hallmark on the block","volume":"84","author":"Mehta","year":"2024","journal-title":"Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08150-0","article-title":"Progressive plasticity during colorectal cancer metastasis","volume":"637","author":"Moorman","year":"2025","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05402-9","article-title":"Metastatic recurrence in colorectal cancer arises from residual EMP1(+) cells","volume":"611","author":"Ca\u00f1ellas-Socias","year":"2022","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41568-022-00497-8","article-title":"Oncofetal reprogramming in tumour development and progression","volume":"22","author":"Sharma","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-02058-1","article-title":"Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer","volume":"57","author":"Mzoughi","year":"2025","journal-title":"Nat Genet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-025-01139-y","article-title":"A patient-derived organoid model captures fetal-like plasticity in colorectal cancer","volume":"35","author":"Xiong","year":"2025","journal-title":"Cell Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09125-5","article-title":"Loss of colonic fidelity enables multilineage plasticity and metastasis","volume":"644","author":"Cammareri","year":"2025","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2024.05.009","article-title":"Activation of fetal-like molecular programs during regeneration in the intestine and beyond","volume":"31","author":"Viragova","year":"2024","journal-title":"Cell Stem Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41568-024-00737-z","article-title":"Cancer drug-tolerant persister cells: from biological questions to clinical opportunities","volume":"24","author":"Russo","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.122.3.467","article-title":"Specific carcinoembryonic antigens of the human digestive system","volume":"122","author":"Gold","year":"1965","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.stem.2017.11.001","article-title":"YAP\/TAZ-dependent reprogramming of colonic epithelium links ECM remodeling to tissue regeneration","volume":"22","author":"Yui","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01654-5","article-title":"Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer","volume":"56","author":"Malla","year":"2024","journal-title":"Nat Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1016\/j.cell.2023.11.004","article-title":"An oncogenic phenoscape of colonic stem cell polarization","volume":"186","author":"Qin","year":"2023","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01088-x","article-title":"Single-cell analyses define a continuum of cell state and composition changes in the Malignant transformation of polyps to colorectal cancer","volume":"54","author":"Becker","year":"2022","journal-title":"Nat Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nature06196","article-title":"Identification of stem cells in small intestine and colon by marker gene Lgr5","volume":"449","author":"Barker","year":"2007","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nature11965","article-title":"Intestinal label-retaining cells are secretory precursors expressing Lgr5","volume":"495","author":"Buczacki","year":"2013","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.01.001","article-title":"Replacement of lost Lgr5-positive stem cells through plasticity of their enterocyte-lineage daughters","volume":"18","author":"Tetteh","year":"2016","journal-title":"Cell Stem Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.stem.2019.12.011","article-title":"Ascl2-dependent cell dedifferentiation drives regeneration of ablated intestinal stem cells","volume":"26","author":"Murata","year":"2020","journal-title":"Cell Stem Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nature15382","article-title":"Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer","volume":"526","author":"Gregorieff","year":"2015","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.cell.2020.11.018","article-title":"Colorectal cancer cells enter a diapause-like DTP state to survive chemotherapy","volume":"184","author":"Rehman","year":"2021","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2023.07.011","article-title":"Mammalian intestinal development and differentiation-the state of the art","volume":"16","author":"Kolev","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.semcdb.2017.01.011","article-title":"Morphogenesis and maturation of the embryonic and postnatal intestine","volume":"66","author":"Chin","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1154-y","article-title":"Single-cell transcriptomes of the regenerating intestine reveal a revival stem cell","volume":"569","author":"Ayyaz","year":"2019","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cell.2012.12.012","article-title":"Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties","volume":"152","author":"Schwitalla","year":"2013","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07135-3","article-title":"SOX17 enables immune evasion of early colorectal adenomas and cancers","volume":"627","author":"Goto","year":"2024","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-026-10344-7","article-title":"Emergence of oncofetal plasticity is ubiquitous in early colorectal cancers","volume":"654","author":"Buissant des Amorie","year":"2026","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116308","article-title":"Mechanosensitive calcium channels and integrins coordinate the reprogramming of colorectal cancer cells into a fetal-like state","volume":"44","author":"van der Net","year":"2025","journal-title":"Cell Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","year":"2012","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.033","article-title":"Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer","volume":"161","author":"Dow","year":"2015","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.12.006","article-title":"Ascl2 acts as an R-spondin\/Wnt-responsive switch to control stemness in intestinal crypts","volume":"16","author":"Schuijers","year":"2015","journal-title":"Cell Stem Cell"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2011.02.020","article-title":"The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse","volume":"8","author":"Merlos-Su\u00e1rez","year":"2011","journal-title":"Cell Stem Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf0927","article-title":"Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation","volume":"9","author":"Bala","year":"2023","journal-title":"Sci Adv"},{"key":"B39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature16466","article-title":"Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function","volume":"529","author":"Storm","year":"2016","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nature21713","article-title":"A distinct role for Lgr5(+) stem cells in primary and metastatic colon cancer","volume":"543","author":"de Sousa e Melo","year":"2017","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nature25492","article-title":"TGF\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nature11282","article-title":"Recurrent R-spondin fusions in colon cancer","volume":"488","author":"Seshagiri","year":"2012","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nature11308","article-title":"Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors","volume":"488","author":"Koo","year":"2012","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-21-3018","article-title":"Comprehensive analysis of R-spondin fusions and RNF43 mutations implicate novel therapeutic options in colorectal cancer","volume":"28","author":"Seeber","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158083","article-title":"New target(s) for RNF43 regulation: Implications for therapeutic strategies","volume":"25","author":"Nag","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0142-z","article-title":"YAP\/TAZ upstream signals and downstream responses","volume":"20","author":"Totaro","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","article-title":"The Hippo pathway: Biology and pathophysiology","volume":"88","author":"Ma","year":"2019","journal-title":"Annu Rev Biochem"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113926","article-title":"The Hippo signaling pathway in development and regeneration","volume":"43","author":"Zhong","year":"2024","journal-title":"Cell Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1038\/s41467-021-22544-y","article-title":"Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP\/TAZ","volume":"12","author":"Della Chiara","year":"2021","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.12.104","article-title":"Tead and AP1 coordinate transcription and motility","volume":"14","author":"Liu","year":"2016","journal-title":"Cell Rep"},{"key":"B51","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.stem.2020.07.003","article-title":"Regenerative reprogramming of the intestinal stem cell state via Hippo signaling suppresses metastatic colorectal cancer","volume":"27","author":"Cheung","year":"2020","journal-title":"Cell Stem Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s43018-019-0006-x","article-title":"L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer","volume":"1","author":"Ganesh","year":"2020","journal-title":"Nat Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3216","article-title":"Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth","volume":"17","author":"Zanconato","year":"2015","journal-title":"Nat Cell Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-16-2821","article-title":"Oncogenic effects of high MAPK activity in colorectal cancer mark progenitor cells and persist irrespective of RAS mutations","volume":"77","author":"Blaj","year":"2017","journal-title":"Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad107","article-title":"Oncogenic YAP mediates changes in chromatin accessibility and activity that drive cell cycle gene expression and cell migration","volume":"51","author":"Fetiva","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.7150\/thno.54027","article-title":"Nodal-induced L1CAM\/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids","volume":"11","author":"Cave","year":"2021","journal-title":"Theranostics"},{"key":"B57","doi-asserted-by":"publisher","first-page":"17365","DOI":"10.1038\/s41598-019-53907-7","article-title":"FGF signalling in the self-renewal of colon cancer organoids","volume":"9","author":"Otte","year":"2019","journal-title":"Sci Rep"},{"key":"B58","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41419-025-07588-y","article-title":"FGFR4 promotes CAF activation through the CXCL10-CXCR3 axis in colon cancer","volume":"16","author":"Sun","year":"2025","journal-title":"Cell Death Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1038\/s41467-025-59588-3","article-title":"Ligand-activated EGFR\/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer","volume":"16","author":"Qu","year":"2025","journal-title":"Nat Commun"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312828","article-title":"The role of EREG\/EGFR pathway in tumor progression","volume":"22","author":"Cheng","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/onco4040019","article-title":"Exploring the potential of epiregulin and amphiregulin as prognostic, predictive, and therapeutic targets in colorectal cancer","volume":"4","author":"Guernsey-Biddle","year":"2024","journal-title":"Onco (Basel)"},{"key":"B62","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-024-01891-4","article-title":"Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3883","article-title":"Fibroblast surface-associated FGF-2 promotes contact-dependent colorectal cancer cell migration and invasion through FGFR-SRC signaling and integrin \u03b1v\u03b25-mediated adhesion","volume":"6","author":"Knuchel","year":"2015","journal-title":"Oncotarget"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3225","article-title":"Stromal gene expression defines poor-prognosis subtypes in colorectal cancer","volume":"47","author":"Calon","year":"2015","journal-title":"Nat Genet"},{"key":"B65","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41568-021-00413-6","article-title":"Overcoming TGF\u03b2-mediated immune evasion in cancer","volume":"22","author":"Tauriello","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02380-2","article-title":"TGF-\u03b2 builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1(+) macrophages","volume":"57","author":"Henriques","year":"2025","journal-title":"Nat Genet"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189198","article-title":"The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies","volume":"1879","author":"Chen","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.08.013","article-title":"Dependency of colorectal cancer on a TGF-\u03b2-driven program in stromal cells for metastasis initiation","volume":"22","author":"Calon","year":"2012","journal-title":"Cancer Cell"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.stem.2023.09.015","article-title":"TGFB1 induces fetal reprogramming and enhances intestinal regeneration","volume":"30","author":"Chen","year":"2023","journal-title":"Cell Stem Cell"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137400","article-title":"TGF-\u03b2 modulated pathways in colorectal cancer: New potential therapeutic opportunities","volume":"25","author":"Fasano","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914815","article-title":"Role of epithelial to mesenchymal transition in colorectal cancer","volume":"24","author":"Lu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2756","article-title":"Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts","volume":"15","author":"Calvo","year":"2013","journal-title":"Nat Cell Biol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41598-019-55687-6","article-title":"Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling","volume":"10","author":"Bauer","year":"2020","journal-title":"Sci Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.87","article-title":"Mechanobiology of YAP and TAZ in physiology and disease","volume":"18","author":"Panciera","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1375543","article-title":"The role of cancer-associated fibroblasts in the invasion and metastasis of colorectal cancer","volume":"12","author":"Yin","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/nature10137","article-title":"Role of YAP\/TAZ in mechanotransduction","volume":"474","author":"Dupont","year":"2011","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.01.001","article-title":"IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer","volume":"15","author":"Grivennikov","year":"2009","journal-title":"Cancer Cell"},{"key":"B78","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2009.01.002","article-title":"gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis","volume":"15","author":"Bollrath","year":"2009","journal-title":"Cancer Cell"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.03.010","article-title":"IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L","volume":"40","author":"Kryczek","year":"2014","journal-title":"Immunity"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/nature03589","article-title":"Notch signals control the fate of immature progenitor cells in the intestine","volume":"435","author":"Fre","year":"2005","journal-title":"Nature"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/nature03659","article-title":"Notch\/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells","volume":"435","author":"van Es","year":"2005","journal-title":"Nature"},{"key":"B82","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccell.2019.08.003","article-title":"Epithelial NOTCH signaling rewires the tumor microenvironment of colorectal cancer to drive poor-prognosis subtypes and metastasis","volume":"36","author":"Jackstadt","year":"2019","journal-title":"Cancer Cell"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/386084a0","article-title":"Homeosis and intestinal tumours in Cdx2 mutant mice","volume":"386","author":"Chawengsaksophak","year":"1997","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1038\/ncomms6728","article-title":"Transformation of intestinal stem cells into gastric stem cells on loss of transcription factor Cdx2","volume":"5","author":"Simmini","year":"2014","journal-title":"Nat Commun"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-09-0401","article-title":"Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer","volume":"15","author":"Baba","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-23-1445","article-title":"Single-cell chromatin accessibility analysis reveals the epigenetic basis and signature transcription factors for the molecular subtypes of colorectal cancers","volume":"14","author":"Liu","year":"2024","journal-title":"Cancer Discov"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial-mesenchymal transition","volume":"21","author":"Yang","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41420-025-02593-8","article-title":"Epithelial-mesenchymal transition in colorectal cancer metastasis and progression: molecular mechanisms and therapeutic strategies","volume":"11","author":"Nie","year":"2025","journal-title":"Cell Death Discov"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(21)00343-0","article-title":"Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer","volume":"22","author":"Zhang","year":"2021","journal-title":"Lancet Oncol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"23381","DOI":"10.1038\/s41598-026-51569-w","article-title":"ANO1 stabilizes partial EMT to drive colorectal cancer metastasis through PI3K\/AKT\/mTOR and ERK signaling pathways","volume":"16","author":"Wu","year":"2026","journal-title":"Sci Rep"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5050051","article-title":"Tumor budding: The name is EMT. Partial EMT","volume":"5","author":"Grigore","year":"2016","journal-title":"J Clin Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/path.6240","article-title":"A partial epithelial-mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restriction","volume":"262","author":"Pastorino","year":"2024","journal-title":"J Pathol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.stem.2020.02.008","article-title":"Plasticity of Lgr5-negative cancer cells drives metastasis in colorectal cancer","volume":"26","author":"Fumagalli","year":"2020","journal-title":"Cell Stem Cell"},{"key":"B96","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1507621","article-title":"Targeting the JAK-STAT pathway in colorectal cancer: mechanisms, clinical implications, and therapeutic potential","volume":"12","author":"Li","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/nature22081","article-title":"Visualization and targeting of LGR5(+) human colon cancer stem cells","volume":"545","author":"Shimokawa","year":"2017","journal-title":"Nature"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05043-y","article-title":"Cell-matrix interface regulates dormancy in human colon cancer stem cells","volume":"608","author":"Ohta","year":"2022","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01100-4","article-title":"Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer","volume":"54","author":"Joanito","year":"2022","journal-title":"Nat Genet"},{"key":"B101","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12943-025-02557-7","article-title":"Cancer stem cell-driven drug resistance in colorectal carcinoma: molecular aspects and therapeutic potentials","volume":"25","author":"Zhou","year":"2026","journal-title":"Mol Cancer"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03796-6","article-title":"Cycling cancer persister cells arise from lineages with distinct programs","volume":"596","author":"Oren","year":"2021","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00402-0","article-title":"Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy","volume":"3","author":"\u00c1lvarez-Varela","year":"2022","journal-title":"Nat Cancer"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010128","article-title":"Patient-derived colorectal cancer organoids upregulate revival stem cell marker genes following chemotherapeutic treatment","volume":"9","author":"Engel","year":"2020","journal-title":"J Clin Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav4474","article-title":"Adaptive mutability of colorectal cancers in response to targeted therapies","volume":"366","author":"Russo","year":"2019","journal-title":"Science"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01105-z","article-title":"A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells","volume":"54","author":"Russo","year":"2022","journal-title":"Nat Genet"},{"key":"B107","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","article-title":"Spatially organized multicellular immune hubs in human colorectal cancer","volume":"184","author":"Pelka","year":"2021","journal-title":"Cell"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","article-title":"Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer","volume":"13","author":"Qi","year":"2022","journal-title":"Nat Commun"},{"key":"B109","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cell.2022.12.028","article-title":"Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer","volume":"186","author":"Lin","year":"2023","journal-title":"Cell"},{"key":"B110","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.celrep.2019.12.075","article-title":"Periostin promotes colorectal tumorigenesis through integrin-FAK-Src pathway-mediated YAP\/TAZ activation","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Rep"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B112","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the roots of cancer","volume":"29","author":"Zanconato","year":"2016","journal-title":"Cancer Cell"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/cells14181464","article-title":"Patient-derived tumor organoids to model cancer cell plasticity and overcome therapeutic resistance","volume":"14","author":"Coppo","year":"2025","journal-title":"Cells"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114270","article-title":"Dark force rising: reawakening and targeting of fetal-like stem cells in colorectal cancer","volume":"43","author":"Fey","year":"2024","journal-title":"Cell Rep"},{"key":"B115","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1200\/jco.22.01690","article-title":"Treatment of metastatic colorectal cancer: ASCO guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J Clin Oncol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113355","article-title":"Not all Wnt activation is equal: ligand-dependent versus ligand-independent Wnt activation in colorectal cancer","volume":"12","author":"Kleeman","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.05.048","article-title":"37P Phase II results of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in genetically selected microsatellite stable colorectal cancer patients","volume":"35","author":"Cook","year":"2024","journal-title":"Ann Oncol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00754-9","article-title":"Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers","volume":"5","author":"Chapeau","year":"2024","journal-title":"Nat Cancer"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-04029-3","article-title":"YAP\/TEAD inhibitor VT3989 in solid tumors: a phase 1\/2 trial","volume":"31","author":"Yap","year":"2025","journal-title":"Nat Med"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118056","article-title":"Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomics","volume":"300","author":"Scalvini","year":"2025","journal-title":"Eur J Med Chem"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02649-z","article-title":"Inhibition of the AURKA\/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells","volume":"130","author":"Rio-Vilari\u00f1o","year":"2024","journal-title":"Br J Cancer"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2025.201032","article-title":"Aurora kinase A drives non-canonical YAP1\/TAZ crosstalk to sustain primary resistance to anti-EGFR therapies in colorectal cancer","volume":"33","author":"Rio-Vilari\u00f1o","year":"2025","journal-title":"Mol Ther Oncol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70103","article-title":"Targeting CDK4\/6 suppresses colorectal cancer by destabilizing YAP1","volume":"6","author":"Wen","year":"2025","journal-title":"MedComm (2020)"},{"key":"B124","doi-asserted-by":"publisher","first-page":"9374","DOI":"10.1038\/s41467-025-64426-7","article-title":"Targeted degradation of endogenous YAP by nanobody bioPROTAC inhibits tumor progression","volume":"16","author":"Zhou","year":"2025","journal-title":"Nat Commun"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37829","article-title":"Targeted degradation of specific TEAD paralogs by small molecule degraders","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"key":"B126","doi-asserted-by":"publisher","first-page":"Abstract nr LB438","DOI":"10.1158\/1538-7445.Am2025-lb438","article-title":"Discovery of a potent and selective pan-TEAD PROTAC directly targeting TEAD-YAP interaction with durable degradation activity [abstract","volume":"85","author":"Zhao","year":"2025","journal-title":"Cancer Res"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09916-w","article-title":"MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance","volume":"650","author":"White","year":"2026","journal-title":"Nature"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf069","article-title":"A phase II, multicenter, single-arm study of pemigatinib in patients with metastatic or unresectable colorectal cancer harboring FGFR alterations","volume":"30","author":"Wheless","year":"2025","journal-title":"Oncologist"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00869-z","article-title":"FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions","volume":"21","author":"Katoh","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102421","article-title":"CANDiT: a machine learning framework for differentiation therapy in colorectal cancer","volume":"6","author":"Sinha","year":"2025","journal-title":"Cell Rep Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/j.gastro.2025.07.003","article-title":"Chemical perturbations impacting histone acetylation govern colorectal cancer differentiation","volume":"170","author":"Likasitwatanakul","year":"2026","journal-title":"Gastroenterology"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1580951","article-title":"Cellular senescence in colorectal cancer: its occurrence, effect and therapy","volume":"15","author":"Liang","year":"2025","journal-title":"Front Oncol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12943-024-02096-7","article-title":"Cellular senescence and SASP in tumor progression and therapeutic opportunities","volume":"23","author":"Dong","year":"2024","journal-title":"Mol Cancer"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-024-00727-x","article-title":"The senescence-associated secretory phenotype and its physiological and pathological implications","volume":"25","author":"Wang","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-23-2804","article-title":"BCL-xL targeting to induce apoptosis and to eliminate chemotherapy-induced senescent tumor cells: from Navitoclax to platelet-sparing BCL-xL PROTACs","volume":"83","author":"Skwarska","year":"2023","journal-title":"Cancer Res"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-025-03280-2","article-title":"ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumors","volume":"134","author":"Sole","year":"2026","journal-title":"Br J Cancer"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03254-6","article-title":"ctDNA-based molecular residual disease and survival in resectable colorectal cancer","volume":"30","author":"Nakamura","year":"2024","journal-title":"Nat Med"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2200075","article-title":"Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer","volume":"386","author":"Tie","year":"2022","journal-title":"N Engl J Med"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.12.006","article-title":"Minimal residual disease in colorectal cancer. Tumor-informed versus tumor-agnostic approaches: unraveling the optimal strategy","volume":"36","author":"Mart\u00ednez-Castedo","year":"2025","journal-title":"Ann Oncol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad007","article-title":"A phase Ib\/II study of WNT974 + encorafenib + cetuximab in patients with BRAF V600E-mutant KRAS wild-type metastatic colorectal cancer","volume":"28","author":"Tabernero","year":"2023","journal-title":"Oncologist"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.3573","article-title":"Efficacy and safety of vactosertib and pembrolizumab combination in patients with previously treated microsatellite stable metastatic colorectal cancer","volume":"39","author":"Kim","year":"2021","journal-title":"J Clin Oncol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS3634","article-title":"Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008","volume":"41","author":"Dasari","year":"2023","journal-title":"J Clin Oncol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-026-04428-0","article-title":"Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial","volume":"32","author":"Bando","year":"2026","journal-title":"Nat Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1912866\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:38:56Z","timestamp":1787657936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1912866\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":143,"alternative-id":["10.3389\/fonc.2026.1912866"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1912866","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1912866"}}